Artificial Intelligence
Life Science Analytics Market to Garner Growth 8.25% by 2030
OTTAWA, Feb. 11, 2021 (GLOBE NEWSWIRE) — The global life science analytics market size accounted at US$ 7.57 billion in 2019 and is expected to reach around US$ 18.12 Billion by 2030, expanding at a CAGR of 8.25% from forecast period 2021 to 2030.
Health care and life sciences analytics is a process of clinical data analysis that offers predictive tools for improved patient care. Analytics play a lead role in the development of various sectors like healthcare, microbiology, and others. The role of analytics in life-science is increasing day by day. The analytics assist the life science firms to transform the raw data into the meaningful insight of life sciences. The data is further utilized by the professionals for the benefit of the patients. Life science analytics helps in the development, discovery, and manufacturing of advanced therapies. Associated courses assist in the firm and government organizations. Life science analytics work on the study which is reported in the form of descriptive, predictive, reporting, and prescriptive based study. Major end-users of these services are medical devices, biotechnology, pharmaceuticals, and others.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1192
What are the Growth Factors?
The growth of the market is mainly associated with its application of advanced analytics. Recently, a high growth rate is seen in the healthcare and medical device sector which directly promotes the growth of the life science analytics market. The use of artificial intelligence and big data analytics is increasing day by day in the healthcare sector, which is also considered as one of the major driving factors which promote the growth of the market. Life science analytics sector is keen to focus on current risks and opportunities for industries.
Technology plays a leading role in current and future development. Rising demand from the end-user industry, especially from the pharmaceutical sector, create prime importance which helps in promoting the growth of the market. However, high cost of implementation followed by a lack of skilled workforce in the area of analytics considered as one of the major restraining factors which affect the growth of the market. Nonetheless, in-depth usage of precision medicine will bring huge growth opportunities within the forecast period.
Report Highlights
- In 2020, descriptive analytics played a lead role in the area of life science analytics market. The same segment occupied the largest share of the revenue generated by global market
- Customers are looking for the best solution from the service providers. In order to obtain operational excellence in the field of healthcare service plays a lead role.
- Based on component type, services segment held the largest market stake in the year 2020.
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1192
Regional Snapshots
North America dominated the global life care analytics market. In the United States, life science analytics play a major role in managing the decision of the healthcare professionals. The firm specialized in the direct transformation program on the large scale. Continuous expansion of the healthcare system is one of the major driving factors for the growth of the U.S. market. The huge capacity of spending followed by increasing economic power in the region is also considered the prime factor for the adoption of the medical device companies. The rising entry of public and private partnerships in the domestic market is a key factor for the market. Countries like Germany, France, and the U.K. in Europe capture the major market share.
The rising penetration of IoT things followed with cloud computing services driving the European market. Increasing the data adaptability approach in Latin America is a key factor that promotes the growth of the market. Middle East countries are also showing keen interest in the area of technological adaption.
Browse more Related Reports
- Life Science Tools Market – The global market value surpassed USD 49.82 billion in 2019 and expected to reach USD 95.68 billion by 2027 and poised to grow at a compound annual growth rate (CAGR) of 8.5% during the forecast period 2020 to 2027.
- mHealth Apps Market – The global market is predicted to reach USD 240.65 billion by 2027 and is anticipated to expand at a compound annual growth rate (CAGR) of 43.9% during the forecast period 2020 to 2027.
- Medical Affairs Outsourcing Market – The global market was valued at US$ 1.43 billion in 2019 and predicted to register a compound annual growth rate (CAGR) of around 10.75% during period 2020 to 2027. The global medical affairs outsourcing market size is projected to reach over US$ 2.8 billion by 2027.
Key Players & Strategies
From the past decade, it is observed that investors are keen to focus on development of the life science care analytics market. The healthcare sector putting forth print in the investment of analytics and other data related apps. With interviews, the top CEOs confirmed that they have trust in the accuracy of predictive analytics. Deloitte played a lead role in the area of analytics, by doing the survey on the regular basis. IBM Watson Health a multibillion-dollar firm provide cloud-based data analytical platform. IBM translates the data into meaningful insights. Per the research, it is observed that 84% of the market leaders considered analytics as a key tool to analyze the upcoming challenges in the healthcare sectors. Recently, the pandemic of the COVID 19, underpinned the importance of analyzing future with various upcoming risk perspectives. With a slow economic recovery, data plays a lead role in the fighting against upcoming challenges.
Some of the players of life sciences analytics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Philips Healthcare, GE Healthcare, Becton, Dickinson and Company, QIAGEN N.V., Roche Diagnostics, Abbott Laboratories, Inc., Siemens Healthcare, C.R. Bard, Inc. and Others.
Market Segmentation
By Type
- Descriptive Analytics
- Predictive Analytics
- Prescriptive Analytics
- Diagnostic Analytics
- Discovery Analytics
By Component Type
- Services
- Software
By Delivery Model
- On-premise model
- On-demand model
By Application Type
- Research & Development
- Preclinical Trials
- Clinical Trials
- Sales & Marketing
- Regulatory Compliance
- Supply Chain Optimization
- Pharmacovigilance
By End Users Type
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
- Research Centers
- Third-party Administrators
By Regional Outlook
- North America
- Europe
- K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- Southeast Asia
- Middle East and Africa
- GCC
- North Africa
- South Africa
- Rest of MEA
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1192
You can place an order or ask any questions, please feel free to contact at [email protected] | +1 774 402 6168
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
Artificial Intelligence
XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform
CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.
XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html
Artificial Intelligence
ICIS and Base Oil News Announce Partnership to Enhance Market Insights
LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.
With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html
Artificial Intelligence
Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform
SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.
Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html
-
Artificial Intelligence7 days ago
Document Collaboration Hub (DCH) by Netcare International Now Available on Microsoft AppSource
-
Artificial Intelligence7 days ago
Smartkem Commences Project with RiTdisplay To Develop World’s First Commercially Ready Active-Matrix OLED Display Using OTFT Technology
-
Artificial Intelligence7 days ago
Hexaware Dominates Whitelane Research 2024 BeLux IT Sourcing Study: A Triumph in Continued CSAT Excellence
-
Artificial Intelligence6 days ago
World System Integrator Conference (WSIC) 2024 A Showcase of New Initiatives
-
Artificial Intelligence7 days ago
Wine of Moldova offers a glimpse of the future with its game-changing AI tool
-
Artificial Intelligence7 days ago
Disaster Preparedness Systems Market Projected to Reach $300.20 billion by 2030 – Exclusive Report by 360iResearch
-
Artificial Intelligence7 days ago
Decision Intelligence Market worth $50.1 billion by 2030 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence7 days ago
YASH Technologies Partners with Baheya Foundation to Transform Cancer Care in Egypt